HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lars Maegdefessel Selected Research

Cardiac Catheters

4/2010Efficacy of enoxaparin, certoparin and dalteparin in preventing cardiac catheter thrombosis: an in vitro approach.
4/2010The direct thrombin inhibitor argatroban effectively prevents cardiac catheter thrombosis in vitro.
10/2008Comparison of bivalirudin, enoxaparin, and unfractionated heparin in preventing cardiac catheter thrombosis. Results of an in-vitro study.
6/2008In-vitro comparison of fondaparinux, unfractionated heparin, and enoxaparin in preventing cardiac catheter-associated thrombus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lars Maegdefessel Research Topics

Disease

25Atherosclerosis
10/2022 - 01/2009
23Inflammation (Inflammations)
10/2022 - 01/2009
19Aneurysm (Aneurysms)
09/2022 - 09/2011
18Abdominal Aortic Aneurysm
09/2022 - 01/2011
14Atherosclerotic Plaque (Atheroma)
02/2022 - 03/2014
13Thrombosis (Thrombus)
01/2021 - 11/2006
11Vascular Diseases (Vascular Disease)
01/2022 - 01/2013
10Rupture
09/2022 - 09/2011
8Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 03/2014
7Coronary Artery Disease (Coronary Atherosclerosis)
10/2022 - 05/2015
7Hyperplasia
01/2022 - 05/2012
7Stroke (Strokes)
12/2021 - 09/2008
5Carotid Stenosis (Carotid Artery Stenosis)
02/2022 - 02/2017
4Fibrosis (Cirrhosis)
06/2021 - 01/2014
4Coronary Disease (Coronary Heart Disease)
05/2014 - 01/2009
3Carotid Artery Diseases
01/2022 - 10/2016
3Disease Progression
01/2021 - 02/2012
3Heart Failure
01/2020 - 04/2016
3Hypoxia (Hypoxemia)
01/2019 - 10/2016
3Myocardial Infarction
04/2016 - 09/2008
3Thromboembolism
11/2011 - 03/2010
3Hemorrhage
11/2011 - 09/2008
3Atrial Fibrillation
05/2010 - 09/2008
2Aortic Aneurysm (Aneurysm, Aortic)
01/2021 - 06/2016
2Aortic Dissection
01/2021 - 01/2018
2Peripheral Arterial Disease
02/2019 - 02/2014
2Aortic Rupture
01/2018 - 02/2012
2Type 2 Diabetes Mellitus (MODY)
08/2015 - 02/2010
2Diabetes Mellitus
08/2015 - 02/2010
2Thrombocytopenia (Thrombopenia)
06/2009 - 06/2009
1Vascular Calcification
01/2022
1Chronic Renal Insufficiency
01/2022
1Vascular Remodeling
01/2021

Drug/Important Bio-Agent (IBA)

19MicroRNAs (MicroRNA)IBA
01/2022 - 05/2013
12Apolipoproteins E (ApoE)IBA
02/2022 - 09/2011
8Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2014
8Angiotensin IIIBA
01/2021 - 09/2011
8Pancreatic Elastase (Elastase)IBA
01/2021 - 01/2011
7RNA (Ribonucleic Acid)IBA
10/2022 - 05/2015
7Biomarkers (Surrogate Marker)IBA
09/2022 - 09/2011
7Long Noncoding RNAIBA
11/2021 - 01/2018
7LipidsIBA
12/2020 - 03/2014
7Heparin (Liquaemin)FDA LinkGeneric
11/2011 - 11/2006
7AnticoagulantsIBA
09/2010 - 11/2006
6Transcription Factors (Transcription Factor)IBA
10/2022 - 05/2015
6Enoxaparin (Lovenox)FDA LinkGeneric
11/2011 - 06/2008
5CholesterolIBA
01/2022 - 07/2015
5mouse MIRN29 microRNAIBA
06/2021 - 01/2012
5Messenger RNA (mRNA)IBA
12/2020 - 10/2016
5Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
11/2011 - 11/2006
3CollagenIBA
09/2022 - 12/2018
3InterferonsIBA
02/2022 - 10/2016
3LDL Receptors (LDL Receptor)IBA
01/2021 - 10/2018
3Pharmaceutical PreparationsIBA
01/2021 - 05/2010
3Histones (Histone)IBA
01/2021 - 01/2019
3ChemokinesIBA
11/2020 - 01/2009
3Antisense OligonucleotidesIBA
01/2020 - 01/2012
3Untranslated RNA (Noncoding RNA)IBA
01/2020 - 06/2016
3CytokinesIBA
10/2017 - 10/2016
3AntithrombinsIBA
09/2010 - 03/2010
3DabigatranFDA Link
09/2010 - 03/2010
3argatroban (MPQA)FDA Link
04/2010 - 06/2009
3Fondaparinux (Arixtra)FDA Link
10/2008 - 11/2006
2Complement System Proteins (Complement)IBA
10/2022 - 01/2020
2Proteoglycans (Proteoglycan)IBA
09/2022 - 01/2021
2ElastinIBA
06/2021 - 02/2019
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2020 - 04/2009
2Small Interfering RNA (siRNA)IBA
01/2019 - 05/2015
2ApolipoproteinsIBA
01/2019 - 10/2018
2Cyclin-Dependent Kinase Inhibitor p15IBA
01/2019 - 03/2014
2Peptide Hydrolases (Proteases)FDA Link
01/2018 - 01/2014
2RivaroxabanIBA
11/2011 - 03/2010
2Warfarin (Coumadin)FDA LinkGeneric
05/2010 - 03/2010
2FibrinIBA
04/2010 - 04/2010
2Eptifibatide (Integrilin)FDA Link
04/2010 - 06/2008
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
03/2010 - 09/2008
2Clopidogrel (Plavix)FDA Link
03/2010 - 09/2008
2Insulin (Novolin)FDA Link
02/2010 - 01/2009
2bivalirudin (Angiomax)FDA Link
06/2009 - 10/2008
1TransposasesIBA
10/2022
1Activating Transcription Factor 3IBA
10/2022
1ChromatinIBA
10/2022
1Dermatan SulfateIBA
09/2022
1osteoadherinIBA
01/2022
1Platelet-Derived Growth FactorIBA
01/2022
1Soluble Guanylyl CyclaseIBA
01/2022
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2022
1Miat long non-coding RNAIBA
11/2021
1Norepinephrine (Noradrenaline)FDA LinkGeneric
10/2021
1LipopolysaccharidesIBA
01/2021
1AminopropionitrileIBA
01/2021

Therapy/Procedure

19Therapeutics
01/2022 - 05/2010
6Catheters
01/2020 - 06/2008
4Cardiac Catheters
04/2010 - 06/2008
3Carotid Endarterectomy
02/2022 - 01/2019
2Ligation
10/2019 - 11/2017
2Stents
09/2015 - 05/2012
2Percutaneous Coronary Intervention
09/2008 - 06/2008
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
11/2021
1Vascular Surgical Procedures
01/2021